Actinic cheilitis: a systematic review of the use of topical anti-inflammatory and antineoplastic agents
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology(2022)
Abstract
Objectives A systematic review was conducted to analyze the use of topical agents in the treatment of actinic cheilitis (AC) as well as patient acceptability. Study Design A systematic review of clinical studies was conducted following the patient, intervention, comparision and outcome (PICO) strategy to answer the following question: Are topical anti-inflammatory and antineoplastic agents effective in the treatment of actinic cheilitis? The quality of the studies was assessed by risk of bias-2 tool (ROB-2) and the certainty of evidence was rated by grading of recommendations assessment, development and evaluation (GRADE) guidelines. Results Eight clinical studies were selected: 4 investigated the use of anti-inflammatory drugs and 4 the use of antineoplastic. The use of 3% diclofenac sodium, fludroxycortide 0.125 mg/g, imiquimod 5%, and ingenol mebutate were associated with partial and/or complete remission of AC. Furthermore, 5-fluorouracil 5% was the drug most associated with complications during treatment. Diclofenac sodium (3%) and fludroxycortide showed the best acceptance by patients, especially for symptom relief and less adverse reactions. Conclusions The anti-inflammatory and antineoplastic agents analyzed promoted clinical improvement, with evidence of remission of AC lesions, development of few local adverse reactions during treatment, and good patient adherence. A systematic review was conducted to analyze the use of topical agents in the treatment of actinic cheilitis (AC) as well as patient acceptability. A systematic review of clinical studies was conducted following the patient, intervention, comparision and outcome (PICO) strategy to answer the following question: Are topical anti-inflammatory and antineoplastic agents effective in the treatment of actinic cheilitis? The quality of the studies was assessed by risk of bias-2 tool (ROB-2) and the certainty of evidence was rated by grading of recommendations assessment, development and evaluation (GRADE) guidelines. Eight clinical studies were selected: 4 investigated the use of anti-inflammatory drugs and 4 the use of antineoplastic. The use of 3% diclofenac sodium, fludroxycortide 0.125 mg/g, imiquimod 5%, and ingenol mebutate were associated with partial and/or complete remission of AC. Furthermore, 5-fluorouracil 5% was the drug most associated with complications during treatment. Diclofenac sodium (3%) and fludroxycortide showed the best acceptance by patients, especially for symptom relief and less adverse reactions. The anti-inflammatory and antineoplastic agents analyzed promoted clinical improvement, with evidence of remission of AC lesions, development of few local adverse reactions during treatment, and good patient adherence.
MoreTranslated text
Key words
antineoplastic agents,anti-inflammatory
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined